Speed, Ecstasy Use in Teens Predicts Future Depression

Use of one or both drugs in grade 10 linked to increased depressive symptoms in grade 11

THURSDAY, April 19 (HealthDay News) -- Use of meth/amphetamine and ±3,4-methylenedioxymethamphetamine (MDMA) among adolescents is associated with an increased risk of subsequent depressive symptoms, according to study published online April 19 in the Journal of Epidemiology & Community Health.

Frédéric N. Brière, from the Université de Montréal, and colleagues investigated whether use of meth/amphetamine (speed) and MDMA (ecstasy) was predictive of subsequent depressive symptoms in a sample of 3,880 adolescents from secondary schools in disadvantaged neighborhoods. The association was tested between meth/amphetamine and MDMA use in grade 10 and depressive symptoms, measured on the abridged Center for Epidemiologic Studies-Depression scale, in grade 11.

Following adjustment for pre-existing individual and contextual characteristics, the researchers found that meth/amphetamine and MDMA use in grade 10 significantly increased the likelihood of depressive symptoms in grade 11 (odds ratio [OR], 1.6 and 1.7, respectively). The risk was further increased in concomitant users (OR, 1.9). Neither gender nor pre-existing depressive symptoms affected the association.

"This study has important public health implications for adolescent populations," the authors write. "Our results concur with others and imply a 'principle of caution' in messages targeting adolescents, upholding that MDMA and meth/amphetamine use, particularly when concurrent, likely increases the risk of experiencing disruptions in affective symptomatology."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events